Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest announcement is out from 4basebio UK Societas ( (GB:4BB) ).
4basebio PLC announced that its COO, Dr. Amy Walker, acquired 1,151 ordinary shares of the company, increasing her total shareholding to 44,016 shares, which represents 0.28% of the issued share capital. This transaction highlights the confidence of the company’s leadership in its strategic direction and potential growth, reinforcing its position in the biotechnology sector.
More about 4basebio UK Societas
4basebio is an innovation-driven biotechnology company focused on the development of advanced therapy medicinal products (ATMPs). It specializes in the large-scale manufacture of synthetic DNA and non-viral, cell-targeting nucleic acid delivery platforms, aiming to lead the market in high-quality synthetic DNA products for research, therapeutic, and pharmacological use.
YTD Price Performance: -4.13%
Average Trading Volume: 891
Technical Sentiment Consensus Rating: Hold
Current Market Cap: £179.5M
Find detailed analytics on 4BB stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue